Loading...
The predictive value of ERCC1 and p53 for the effect of panobinostat and cisplatin combination treatment in NSCLC
Cisplatin is one of the most common chemotherapeutic drugs for non-small cell lung cancer (NSCLC). However, the response rate is limited because of drug resistance. Histone deacetylase inhibitors (HDACis), which can alter DNA accessibility by regulating chromatin structure and inducing apoptosis, ex...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4662470/ https://ncbi.nlm.nih.gov/pubmed/25944617 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|